Fed. Circ. Backs $173M Bayer Patent Win On Hemophilia Drug
The Federal Circuit on Monday upheld Bayer's $173 million win in a patent fight with Baxalta over their competing hemophilia treatments, rejecting Baxalta's argument that a Delaware jury mistakenly relied on...To view the full article, register now.
Already a subscriber? Click here to view full article